Craft
  • Home
  •  / Acutus Medical
Acutus Medical

Acutus Medical

Revenue

$2.8 M

FY, 2019

Total Funding

$308.2 M

Acutus Medical Summary

Company summary

Overview
Acutus Medical is committed to pioneering a breakthrough technology to optimize the treatment strategies for complex cardiac arrhythmias by developing innovative, safe, efficacious, and cost-effective solutions for individuals suffering from these complex cardiac arrhythmias. Our mission is to develop and market a platform technology of safe, cost-effective and clinically advanced tools for the minimally invasive diagnosis (mapping) of complex arrhythmias (Atrial Fibrillation and Ventricular Tachycardia) that enable Physicians to optimize treatments and expand the ablation/therapeutic markets. In the pursuit of our mission, we will conduct all of our activities with the highest integrity and strive to become the world’s most valued company within the markets we serve to patients, customers, colleagues, investors, business partners, employees, and the communities in which we work and live. Located in San Diego, California, the company was founded in 2011 by a creative Theoretical Physicist, an Electrophysiologist and a San Diego entrepreneur around the concept of a new breakthrough technology in electrophysiology.
Type
Private
Status
Active
Founded
2011
HQ
Carlsbad, CA, US | view all locations
Website
http://acutusmedical.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key people

  • Scott Huennekens

    Scott Huennekens, Executive Chairman of the Board

  • Vince Burgess

    Vince Burgess, President and Chief Executive Officer and Director

  • David H Roman

    David H Roman, Chief Financial Officer

LocationsView all

2 locations detected

  • Carlsbad, CA HQ

    United States

    2210 Faraday Ave #100

  • Zaventem, Vlaanderen

    Belgium

    25 Ikaroslaan

Acutus Medical Financials

Summary financials

Revenue (Q1, 2020)
$1.6M
Gross profit (Q1, 2020)
($1.6M)
Net income (Q1, 2020)
($18.1M)
Cash (Q1, 2020)
$21.0M
EBIT (Q1, 2020)
($17.6M)

Footer menu